Secondary alkyl hydroperoxides as inhibitors and alternate substrates for lipoxygenase.
Lipoxygenase plays a central role in polyunsaturated fatty acid metabolism, inaugurating the biosynthesis of eicosanoids in animals and phytooxylipins in plants. Redox cycling of the non-heme iron cofactor represents a critical element of the catalytic mechanism. Paradoxically, the isolated enzyme contains Fe(II), but the catalytically active form contains Fe(III), and the natural oxidant for the iron is the hydroperoxide product of the catalyzed reaction. Controlling the redox state of lipoxygenase iron with small molecules, inhibitors or activators, could be a means to modulate the activity of the enzyme. The effects of secondary alkyl hydroperoxides and the corresponding alcohols on soybean lipoxygenase-1 reaction rates were investigated and found to be very different. Secondary alcohols were noncompetitive or linear mixed inhibitors with inhibition constants in the millimolar concentration range, with more hydrophobic compounds producing lower values. Secondary alkyl hydroperoxides were inhibitors of lipoxygenase-1 primarily at high substrate concentration. They were more effective inhibitors than the alcohols, with dissociation constants in the micromolar concentration range. The hydroperoxides bearing longer alkyl substituents were the more effective inhibitors. Oxidation of the iron in lipoxygenase-1 by 2-hydroperoxyalkanes was evident in electron paramagnetic resonance (EPR) measurements, but the enzyme was neither activated nor was it inactivated. Instead there was evidence for an entirely different reaction catalyzed by the enzyme, a homolytic dehydration of the hydroperoxide to produce the corresponding carbonyl compound.
Waller
Tiffany M
TM
Department of Chemistry, University of Toledo, 2801 West Bancroft Street, Toledo, Ohio 43606, USA.
Decker
Ilka
I
Frisch
Jonathan P
JP
Kernstock
Robert M
RM
Kim
Yong-Wah
YW
Funk
Max O
MO
D002151:Calorimetry; D004578:Electron Spin Resonance Spectroscopy; D005233:Fatty Alcohols / Q000737:chemistry / Q000378:metabolism; D005290:Ferric Compounds / Q000737:chemistry / Q000378:metabolism; D005296:Ferrous Compounds / Q000737:chemistry / Q000378:metabolism; D006861:Hydrogen Peroxide / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D007700:Kinetics; D008041:Linoleic Acids / Q000737:chemistry / Q000378:metabolism; D008084:Lipoxygenase / Q000378:metabolism*; D016859:Lipoxygenase Inhibitors / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D008954:Models, Biological; D010084:Oxidation-Reduction / Q000187:drug effects; D013379:Substrate Specificity
D005233:Fatty Alcohols; D005290:Ferric Compounds; D005296:Ferrous Compounds; D008041:Linoleic Acids; D016859:Lipoxygenase Inhibitors; D006861:Hydrogen Peroxide; C101084:lipoxygenase L-1; D008084:Lipoxygenase